CEO Thomas Andrew Crockett sold $172K of KalVista Pharmaceuticals, Inc.

Sold$171,841

$17.18Price

10,000Shares

−7%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Fri, Oct 1. Filed Mon, Oct 4, 12:57 PM ET, during the session. Not investment advice.